Kaya Holdings (KAYS) Liabilities and Shareholders Equity (2011 - 2025)

Kaya Holdings (KAYS) recorded quarterly Liabilities and Shareholders Equity of $199358.0 in Q3 2025, down 21.65% quarter-over-quarter from $254430.0 in Q2 2025, and down 25.78% on a YoY basis from $268589.0 in Q3 2024.

Kaya Holdings (KAYS) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends

Kaya Holdings' Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $199358.0 for Q3 2025.

  • In Q3 2025, Liabilities and Shareholders Equity fell 25.78% year-over-year to $199358.0; the TTM figure through Sep 2025 stood at $867446.0 (down 14.35% YoY), while the FY2024 annual figure was $216369.0, changed 0.24% from the prior year.
  • Liabilities and Shareholders Equity was $199358.0 for Q3 2025 at Kaya Holdings, down from $254430.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 million in Q1 2021 to a low of $197289.0 in Q1 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $788176.8 across 5 years, with a median of $300680.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity tumbled 76.02% in 2023, then gained 17.13% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.6 million in 2021, then tumbled by 46.26% to $843241.0 in 2022, then sank by 74.4% to $215856.0 in 2023, then increased by 0.24% to $216369.0 in 2024, then slipped by 7.86% to $199358.0 in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $199358.0 (Q3 2025), $254430.0 (Q2 2025), and $197289.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Kaya Holdings - - 5,370.00 199,358.00

Historic Data

Download Data
DateValue
Sep 30, 2025 199,358.00
Jun 30, 2025 254,430.00
Mar 31, 2025 197,289.00
Dec 31, 2024 216,369.00
Sep 30, 2024 268,589.00
Jun 30, 2024 300,680.00
Mar 31, 2024 227,614.00
Dec 31, 2023 215,856.00
Sep 30, 2023 230,550.00
Jun 30, 2023 256,709.00
Mar 31, 2023 304,879.00
Dec 31, 2022 843,241.00
Sep 30, 2022 961,522.00
Jun 30, 2022 987,515.00
Mar 31, 2022 1.18 Mn
Dec 31, 2021 1.57 Mn
Sep 30, 2021 2.20 Mn
Jun 30, 2021 2.27 Mn
Mar 31, 2021 2.30 Mn
Dec 31, 2020 2.30 Mn